| Value | ₹1,000 Cr |
|---|
NSE filing, NSE: AADHARHFC. Summary written from the filing by ALFA Finder's alert engine.
Aadhar Housing Finance Ltd: key numbers
- Share price
- ₹420.10
- Market cap
- ₹18,417 Cr
- Revenue (annual)
- ₹3,673 Cr
- Net profit (annual)
- ₹1,096 Cr
- P/E (TTM)
- 16.1×Sector 19.8×
- Promoter holding
- 64.51%-0.15% QoQ
- FII holding
- 4.11%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Aadhar Housing Finance Ltd
All →Aadhar Housing Finance Board Meeting Date
Aadhar Housing Finance will hold a board meeting on November 5, 2026 to consider unaudited standalone and consolidated results for the quarter and half year ended September 30, 2026. The filing is a prior intimation, and the trading window is closed from October 1, 2026.
Aadhar Housing Finance Debt & Borrowing: ₹0.45 Cr
Aadhar Housing Finance paid Rs 45.05 lakh monthly NCD interest on its due date. Payment was made after TDS deduction, with no delay.
- Value
- ₹0.45 Cr
Aadhar Housing Finance Debt & Borrowing: ₹5.98 Cr
Aadhar Housing Finance confirmed timely quarterly interest payment of ₹5.98 Crore on its Rs.350 Crore NCDs. Payment executed on 21 October 2026 due to Dusshera holiday.
- Value
- ₹5.98 Cr
Aadhar Housing Finance Debt & Borrowing: ₹7 Cr
Aadhar Housing Finance has successfully redeemed its NCDs (Series 0009) upon maturity. The company paid a total redemption amount of Rs. 7.00 Crore.
- Value
- ₹7.00 Cr
Aadhar Housing Finance Debt & Borrowing: ₹0.65 Cr
Aadhar Housing Finance paid Rs.0.65 Crore as annual interest on its non-convertible debentures. The payment was made on its due date.
- Value
- ₹0.65 Cr
Aadhar Housing Finance Debt & Borrowing: ₹7.65 Cr
Aadhar Housing Finance paid Rs. 7.65 Crore covering principal redemption and interest for its non-convertible debentures (ISIN: INE538L08096) upon their maturity.
- Value
- ₹7.65 Cr
Other fund raise announcements
All →Sudarshan Pharma Industries Fund Raise of ₹72 Cr
Sudarshan Pharma's board approved up to Rs. 72 Crore of preferential convertible warrants for promoters Hemal and Sachin Mehta. Shareholder approval will be sought at an EGM.
- Value
- ₹72.00 Cr
Flywings Simulator Training Centre Fund Raise of ₹68.2 Cr
Flywings Simulator's board approved Rs. 68.20 Crore fully convertible warrants on a preferential basis. Promoter Rupal Mandavia is allotted Rs. 25 Crore, subject to shareholder approval.
- Value
- ₹68.20 Cr
Kanel Industries Fund Raise of ₹16.99 Cr
Kanel Industries' board approved a rights issue of 42.52 lakh equity shares at Rs.39.95 each. The issue aggregates about Rs.16.99 Crore, with record date 13 November 2026.
- Value
- ₹16.99 Cr
- Execution
- Rights issue opens 23 November 2026 and closes 30 November 2026
Sudarshan Pharma Industries Fund Raise
Board approved issuing up to 72 Crore warrants to promoters on a preferential basis. Pricing per Reg 164 is pending, with no fixed rupee value stated.
GAIL (India) Fund Raise
GAIL Board approved in principle the IPO of subsidiary GAIL Gas Limited on Indian exchanges. GAIL will dilute its GGL equity up to 25%.
Gujarat Inject (Kerala) Fund Raise of ₹3 Cr
Gujarat Inject Kerala's board approved a Rs.3 Crore preferential warrant issue to public investors. Authorised capital will rise to Rs.17.63 Crore, subject to shareholder approval.
- Value
- ₹3.00 Cr